Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15918-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15918-1-AP, RRID:AB_11126973
- Product name
- AMACR/p504S antibody
- Antibody type
- Polyclonal
- Description
- AMACR/p504S antibody (Cat. #15918-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Identification of PRDX5 as A Target for The Treatment of Castration-Resistant Prostate Cancer.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Circ_0076305 facilitates prostate cancer development via sponging miR-411-5p and regulating PGK1.
SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.
The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer.
Wang R, Mi Y, Ni J, Wang Y, Ding L, Ran X, Sun Q, Tan SY, Koeffler HP, Feng N, Chen YQ
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Mar;11(9):e2304939
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Mar;11(9):e2304939
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Garnham R, Geh D, Nelson R, Ramon-Gil E, Wilson L, Schmidt EN, Walker L, Adamson B, Buskin A, Hepburn AC, Hodgson K, Kendall H, Frame FM, Maitland N, Coffey K, Strand DW, Robson CN, Elliott DJ, Heer R, Macauley M, Munkley J, Gaughan L, Leslie J, Scott E
Communications biology 2024 Mar 6;7(1):276
Communications biology 2024 Mar 6;7(1):276
Circ_0076305 facilitates prostate cancer development via sponging miR-411-5p and regulating PGK1.
Ding X, Sun J, Zhang X
Andrologia 2022 Jul;54(6):e14406
Andrologia 2022 Jul;54(6):e14406
SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.
Xiao ZM, Lv DJ, Yu YZ, Wang C, Xie T, Wang T, Song XL, Zhao SC
Frontiers in cell and developmental biology 2021;9:678967
Frontiers in cell and developmental biology 2021;9:678967
The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer.
Yang D, Shi X, Lei Y, Zhou X, Chen Q
Oncology letters 2020 Aug;20(2):1418-1422
Oncology letters 2020 Aug;20(2):1418-1422
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The AMACR/p504S antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human AMACR/p504S. This antibody recognizes human antigen. The AMACR/p504S antibody has been validated for the following applications: ELISA, IHC, WB analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human prostate cancer using 15918-1-AP(p504S,AMACR antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human prostate cancer using 15918-1-AP(p504S,AMACR antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue
